86 related articles for article (PubMed ID: 10993227)
1. Interactions between local anesthetics and Na+ channel inactivation gate peptides in phosphatidylserine suspensions as studied by 1H-NMR spectroscopy.
Kuroda Y; Miyamoto K; Tanaka K; Maeda Y; Ishikawa J; Hinata R; Otaka A; Fujii N; Nakagawa T
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1293-8. PubMed ID: 10993227
[TBL] [Abstract][Full Text] [Related]
2. 1H-NMR and circular dichroism spectroscopic studies on changes in secondary structures of the sodium channel inactivation gate peptides as caused by the pentapeptide KIFMK.
Kuroda Y; Maeda Y; Miyamoto K; Tanaka K; Kanaori K; Otaka A; Fujii N; Nakagawa T
Biophys J; 1999 Sep; 77(3):1363-73. PubMed ID: 10465748
[TBL] [Abstract][Full Text] [Related]
3. Locations of local anesthetic dibucaine in model membranes and the interaction between dibucaine and a Na+ channel inactivation gate peptide as studied by 2H- and 1H-NMR spectroscopies.
Kuroda Y; Ogawa M; Nasu H; Terashima M; Kasahara M; Kiyama Y; Wakita M; Fujiwara Y; Fujii N; Nakagawa T
Biophys J; 1996 Sep; 71(3):1191-207. PubMed ID: 8873993
[TBL] [Abstract][Full Text] [Related]
4. Helix-stabilizing effects of the pentapeptide KIFMK and its related peptides on the sodium channel inactivation gate peptides.
Maeda Y; Nakagawa T; Kuroda Y
J Pept Res; 2001 Nov; 58(5):413-23. PubMed ID: 11892850
[TBL] [Abstract][Full Text] [Related]
5. Structural study of the sodium channel inactivation gate peptide including an isoleucine-phenylalanine-methionine motif and its analogous peptide (phenylalanine/glutamine) in trifluoroethanol solutions and SDS micelles.
Kuroda Y; Miyamoto K; Matsumoto M; Maeda Y; Kanaori K; Otaka A; Fujii N; Nakagawa T
J Pept Res; 2000 Sep; 56(3):172-84. PubMed ID: 11007274
[TBL] [Abstract][Full Text] [Related]
6. Solution structures of the inactivation gate particle peptides of rat brain type-IIA and human heart sodium channels in SDS micelles.
Miyamoto K; Kanaori K; Nakagawa T; Kuroda Y
J Pept Res; 2001 Mar; 57(3):203-14. PubMed ID: 11298921
[TBL] [Abstract][Full Text] [Related]
7. The conformation and movement of Na channel inactivation gate peptide in linker between domain III and IV during inactivation by NMR spectroscopy and molecular modeling study.
Lou BS; Lin TH; Lo CZ
J Pept Res; 2004 Mar; 63(3):313-23. PubMed ID: 15049844
[TBL] [Abstract][Full Text] [Related]
8. Block of brain sodium channels by peptide mimetics of the isoleucine, phenylalanine, and methionine (IFM) motif from the inactivation gate.
Eaholtz G; Colvin A; Leonard D; Taylor C; Catterall WA
J Gen Physiol; 1999 Feb; 113(2):279-94. PubMed ID: 9925825
[TBL] [Abstract][Full Text] [Related]
9. Solution structures of the cytoplasmic linkers between segments S4 and S5 (S4-S5) in domains III and IV of human brain sodium channels in SDS micelles.
Miyamoto K; Nakagawa T; Kuroda Y
J Pept Res; 2001 Sep; 58(3):193-203. PubMed ID: 11576325
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the cytoplasmic linker between domain III-S6 and domain IV-S1 (III-IV linker) of the rat brain sodium channel in SDS micelles.
Miyamoto K; Nakagawa T; Kuroda Y
Biopolymers; 2001 Oct; 59(5):380-93. PubMed ID: 11514941
[TBL] [Abstract][Full Text] [Related]
11. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
12. Interaction of local anesthetics with a peptide encompassing the IV/S4-S5 linker of the Na+ channel.
Fraceto LF; Oyama S; Nakaie CR; Spisni A; de Paula E; Pertinhez TA
Biophys Chem; 2006 Aug; 123(1):29-39. PubMed ID: 16687202
[TBL] [Abstract][Full Text] [Related]
13. Suppression of insulin signalling by a synthetic peptide KIFMK suggests the cytoplasmic linker between DIII-S6 and DIV-S1 as a local anaesthetic binding site on the sodium channel.
Hirose M; Kuroda Y; Sawa S; Nakagawa T; Hirata M; Sakaguchi M; Tanaka Y
Br J Pharmacol; 2004 May; 142(1):222-8. PubMed ID: 15037518
[TBL] [Abstract][Full Text] [Related]
14. Structural and gating changes of the sodium channel induced by mutation of a residue in the upper third of IVS6, creating an external access path for local anesthetics.
Sunami A; Glaaser IW; Fozzard HA
Mol Pharmacol; 2001 Apr; 59(4):684-91. PubMed ID: 11259611
[TBL] [Abstract][Full Text] [Related]
15. Voltage-sensitive sodium channels: agents that perturb inactivation gating.
Agnew WS; Cooper EC; Shenkel S; Correa AM; James WM; Ukomadu C; Tomiko SA
Ann N Y Acad Sci; 1991; 625():200-23. PubMed ID: 1647724
[TBL] [Abstract][Full Text] [Related]
16. Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.
Kimbrough JT; Gingrich KJ
J Physiol; 2000 Nov; 529 Pt 1(Pt 1):93-106. PubMed ID: 11080254
[TBL] [Abstract][Full Text] [Related]
17. Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels.
Ahern CA; Eastwood AL; Dougherty DA; Horn R
Circ Res; 2008 Jan; 102(1):86-94. PubMed ID: 17967784
[TBL] [Abstract][Full Text] [Related]
18. Altered gating and local anesthetic block mediated by residues in the I-S6 and II-S6 transmembrane segments of voltage-dependent Na+ channels.
Kondratiev A; Tomaselli GF
Mol Pharmacol; 2003 Sep; 64(3):741-52. PubMed ID: 12920212
[TBL] [Abstract][Full Text] [Related]
19. Sodium channel inactivation is altered by substitution of voltage sensor positive charges.
Kontis KJ; Goldin AL
J Gen Physiol; 1997 Oct; 110(4):403-13. PubMed ID: 9379172
[TBL] [Abstract][Full Text] [Related]
20. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
